Financial support: U-Inicia VID Research Project
DEPLETION STUDY OF OXYTETRACYCLINE (OTC) AND ITS METABOLITE 4-EPI-OXYTETRACYCLINE RESIDUES (4-EPI-OTC) IN CLAWS OF BROILER
CHICKENS BY LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS)
JAVIERA CORNEJO, EKATERINA POKRANT, DANIELA ARAYA, ALDO MADDALENO, CAROLINA ARAYA-JORDÁN, HECTOR HIDALGO, BETTY SAN MARTIN.
Oxytetracycline (OTC) is an antimicrobial from the tetracyclines family, authorized for therapeutic use in poultry to combat infectious diseases
It is often administered orally through medicated water or feed in the case of out-breaks
It is quickly absorbed by the gastrointestinal tract, being widely distributed throughout the organism and reaching high levels in kidneys and liver
They may persist as chemical residues in food affecting their safety risk to consumers’ health.
INTRODUCTION
INTRODUCTION
• Risks of tetracycline residues in food:
• Toxicological effects causing ossification and teething disorders. • This has been reported especially in children, due to the chelating
action of tetracyclines on the calcium ion.• Allergic reactions in individuals who have been previously sensitized
• The introduction of these antimicrobial agents in production systems has created favourable conditions for the selection, propagation and persistence of antimicrobial resistant bacteria, capable of causing infections in animals and humans
• Edible tissues of broiler chickens
Several authors have studied the OTC depletion profile and its metabolite 4-epi-OTC to establish the post-treatment residue levels in chickens’ edible tissues, such as muscle, liver and kidneys
INTRODUCTION
Enough information to evidence that antimicrobials
after therapy completion may remain in tissues for varying times depending on the drug’s elimination kinetics.
• Edible tissues of broiler chickens INTRODUCTION
Scarce information in the literature about the behavior of antimicrobial concentrations in poultry by-products.
Until today there are no studies on the chicken claws.
This by-product may be destined to human consumption directly, or indirectly through claw-meal.
Not considered an edible tissue. No regulations or MRLs established.
INTRODUCTION
EXPORTS
2014
IMPORT
2007US$ 516
MILLiONS
EXPORTS
2013
106%MORE THAN
PREVIUS YEAR
US$19.194MILLIONS
2.72MILLIONS OF METRIC TONS
14.990TONS
5.6%INCREASE
DURING THE LAST FEW YEARS, THE MARKET FOR THIS BY-PRODUCT HAS GROWN.
Slide 6
C15 Esta diapo esta OK solo que esta en español, pero eso lo puedo cvambiar yo despues CLIENTE, 18-5-2016
INTRODUCTION
Chicken claws are basically bone and cartilage, so they may accumulate higher tetraciclines concentrations compared to other tissues due to they affinity for calcium.
Medina et al. (2008) analysed the tetracycline content in bones from slaughterhouse swines and observed that 81% of the analysed samples were positive while 50% of the edible tissues samples were positive.
U.
INTRODUCTION
Körner et al. (2001) studied the incidence of tetracyclineresidues in commercial bone and meat meal samples. They found tetracyclines in all samples with concentrations of up to 2,295 µg kg-1.
Odore et al. (2015) analysed bones samples (breastbone, femur, tibia and fibula) from broilers treated with a therapeutic dose of OTC, by LC MS/MS. They found OTC and 4-epi-OTC levels as high as 1,286 µg kg-1 at day 10 post-treatment.
INTRODUCTION
Chicken claws are basically bone and cartilage, so they may accumulate higher tetraciclines concentrations compared to other tissues due to they affinity for calcium.
Medina et al. (2008) analysed the tetracycline content in bones from slaughterhouse swines and observed that 81% of the analysed samples were positive while 50% of the edible tissues samples were positive.
Körner et al. (2001) studied the incidence of tetracycline residues in commercial bone and meat meal samples. They found tetracyclines in all samples with concentrations of up to 2.295 µg kg-1.
Odore et al. (2015) analysed bones samples (breastbone, femur, tibia and fibula) from broilers treated with a therapeutic dose of OTC, by LC MS/MS. They found OTC and 4-epi-OTC levels as high as 1.286 µg kg-1 at day 10 post-treatment.
INTRODUCTION
These results show the persistence of this drug in the studied tissues. It also gives evidence for the possible re-entry of veterinary drug residues into the food chain.
Moreover, some authors state that due to OTC thermostability this drug is not affected by conventional cooking for human consumption, or by the industrial thermal processes performed in meals, including by-products
CONSUME
INTRODUCTION
• Currently, there are no specific studies on broiler claws assessing the presence of antimicrobial residues.
• The pharmacokinetic characteristics of this antimicrobial would promote the accumulation of residues at higher concentrations during longer periods of time.
• OTC residues may remain in broiler claws evidencing the need of carrying out specific studies in this matrix.
• Considering the potential risk of a re-entrance of antimicrobials into the food chain through this by-product in the present study OTC residues depletion in broiler claws were studied for the first time therapeutically treated broiler chickens.
MATERIALS AND METHODS
EXPERIMENTAL ANIMALS
KEPT IN INDIVIDUAL CAGES
•AD LIBITUM ACCESS TO WATER AND NON-MEDICATED FEED
•25 ± 5°C AND 50–60% RELATIVE HUMIDITY
•THE CAGES HAD AN ELEVATED WIRE FLOOR
BROILER CHICKEN ROSS 308 GENETIC
X 40MALE/ ONE-DAY-OLD
MATERIALS AND METHODS
GROUP WITH AND WITHOUT TREATMENT
WITH TREATMENT•ADMINISTRATED ORALLY ONCE A DAY •THROUGH PREMIX POWDERX 32
GROUPA
X 8GROUP B
WITHOUT TREATMENT
50mg/kg-1
bw of OTC 10%.
X 7 DAYS
CONSECUTIVE
NUMBER OF ANIMALS DETERMINED BY EMA GUIDELINES
MATERIALS AND METHODS
MATERIALS AND METHODS
TREATMENT
DEPLETION STUDY
1 14 15 21 22 28 40BREEDING TREATMENT BEGINS TREATMENT END 7 DAYS WDT END
Day 3 Day 9 Day 15 Day 19
POST TREATMENT SLAUGHTER DAYS AND SAMPLING
GRUOP A
GRUOP B
X 8
X 2SLAUGHTER ANIMALS
MATERIALS AND METHODS
SAMPLES COLLECTION
SAMPLE COLLECTION AND PROCESSING
ALL SAMPLES WERE CHOPPED WITH SCISSORS
SAMPLES HOMOGENIZED IN A FOOD PROCESSOR
STORED IN FRESH BAGS AT -20° C UNTIL EXTRACTION
MATERIALS AND METHODS
ANALYTICAL METHODOLOGY
The method for the extraction of OTC and 4-epi-OTC developed for broiler claws was based on the methods described by Reveurs and Díaz (1994), Khong et al. (2005) and Castellari et al. (2009).
Samples for the implemented analytical method were obtained from previously analysedcommercial broiler claws.
For the analysis and quantification of OTC and 4-epi-OTC in broiler claws, certified standard of purity were used (Dr. Ehren-storfer Gmbh). As internal standard (IS) an isotopically labelled tetracycline (TC-d6) of certified purity was obtained from the Toronto Research Chemicals (Canada).
MATERIALS AND METHODS
MATERIALS AND METHODS
SAMPLE(5 0.05 g)
EXTRACTIONEDTA-MCILVAINE BUFFER
AGITATED AND CENTRIFUGED SUPERNATANT OBTAINED
PURIFICATION THROUGH GLASS WOOL
FILTRATION OF SUPERNATANT IN SPE SEP-PAK C18 COLUMN (PRECONDICIONED WITH HPLC WATER AND ACETONITRILE)
COLUMN ELUTION(WITH 1.0 m METHANOLIC OXALIC ACID)
EVAPORATED UNDER A MILD NITROGEN FLUX (40-50°C)
RECONSTITUTION WITH 250 mL OF MOBILE PHASE (OXALIC ACID 0.01 m/ACETONITRILE, 5:1)
LC VIAL
ANALYTICAL METHODOLOGY
MATERIALS AND METHODS
INSTRUMENTAL ANALYSIS
LC-MS/MS analysis was carried with a liquid chromatograph (Agilent series 3200) coupled to a triple quadrupole mass spectrometer (API 4000, SCIEX).
IONS PRECURSOR ION FRAGMENT ION
OTC y 4-epi-OTC 461.0 426.0
461.0 381.0
TC d-6 (IS) 451.0 416.0
MONITORED ION MASSES.
RESULTS
The analytical method was implemented and then optimized with the aim to improve the analyte recovery.
IMPLEMENTATION OF THE ANALYTICAL METHOD
When the OASIS HLB® SPE columns was used average R2 were 0.869 and 0.908, respectively.
The use of SPE sep-pak C18 instead of the SPE OASIS HLB® gave a better linearity of the calibration curves. Using SPE sep-pak 18 average R2 in the three curves was 0.991 for OTC and 0.983 for 4-epi-OTC.
Increasing centrifugation time allowed improvement of the recoveries of both analytes.
RESULTS
Changes in methodology Results
Reduction of sample size Improves matrix clean up
Increase in centrifugation time Increases recovery
Addition of reagent tris (2-carbaxyethyl) phosphine hydrochloride 98% (TCEP-HCL) No changes in extraction
Centrifugation at 0° C Improves sediment decanting
Hexane addition Decreases recovery
SPE OASIS HLB cartridgeSPE sep-pak C18 cartridge
Decreases recoveryIncreases recovery
Changes made for the improvement of analyte recovery
IMPLEMENTATION OF THE ANALYTICAL METHOD
Validation of the analytical method
• An internal protocol was used for the in-house validation. • Estimation of linearity, repeatability, reproducibility, specificity and recovery (Commission
Decision 2002/657/EC). • LOD – LOQ (FDA, VICH GL49).
• The method fulfil the acceptance criteria for the studied parameters.
• The method can be considered specific, since no interferences were observed at the retention times of the analytes.
RESULTS
ParameterCriteria
Retention time CV -5%
LinearityR2≥0.95
Recovery (%) at LoD level
Repeatability (%) at LoD CV > Repro.
Reproducibility (%) at LOD CV < 23%
LoD(µg kg-1)
LoQ(µg kg-1)
OTC 0.32% 0.9608 97% 13.8 16 20 22
0.9932
0.9930
4-epi-OTC 2.41% 0.9611 116% 10.3 15 20 22
0.9927
0.9801
Summary of validation data for OTC and 4-epi-OTC in claws.
RESULTS
Validation of the analytical method
RESULTS
ParameterCriteria
Retention time CV -5%
LinearityR2≥0.95
Recovery (%) at LoD level
Repeatability (%) at LoD CV >
Repro.
Reproducibility (%) at LOD CV < 23%
LoD(µg kg-1)
LoQ(µg kg-1)
OTC 0.32% 0.9608 97% 13.8 16 20 22
0.9932
0.9930
4-epi-OTC 2.41% 0.9611 116% 10.3 15 20 22
0.9927
0.9801
• An internal protocol was used for the in-
house validation.
Figure 1. Chromatograms representing pure drug injections: (a) OTC retention time (461.0/426.0) and (b) IS TC-d6 retention time (451.0/416.0). Chromatograms of claw blank samples injections: (c) no interferences at the OTC retention time (461.0/426.0) and (d) IS TC-d6 injection (451.0/416.0).
RESULTS
RESULTS
Figure 2. (a) and (b) Chromatograms representative of pure drug injections. (a) 4-epi-OTC retention time (461.0/426.0). (b) IS TC-d6 retention time (451.0/416.0). (c) and (d) Chromatogram of claw blank samples injections. (c) No interferences in 4-epi-OTC retention time (461.0/426.0). (d) IS TC-d6 injection (451.0/416.0).
• in-house validation study
• The method fulfill the acceptance criteria for the validation parameters
• is valid to quantify these analytes on claws in a reliable and precise manner.
• The method can be considered specific, since no interferences were observed at the retention times of the analytes.
ANALYTERETENTION TIME
SPECIFICITY
LOD
LOQLINEARITY
RECOVERY
PRECISION
RESULTS
C51
Slide 28
C51 CLIENTE, 18-5-2016
DETERMINATION OF THE CONCENTRATIONS OF OTC AND 4-EPI-OTC IN CLAWS
• The concentrations of OTC and 4-epi-OTC found in claws from broilers treated therapeutically were evaluated and quantified. Table 5 describes the average concentrations for OTC and 4-epi-OTC at each sampling moment.
RESULTS
SLAUGHTER DAYS
DAYS POST TREATMENT
DAYS OF LIFE
NUMBER OF ANIMALS
OTC AVERAGE CONCENTRATION
(µg/kg)
epi-OTC AVERAGE CONCENTRATION
(µg/kg)
OTC + EPI OTC (µg/kg)
M1 3 24 8 1835 1162 2997
M2 9 30 6 984 370 1354
M3 15 36 7 157 154 311
M4 19 40 7 20 84 104
RESULTS
• The withdrawal time for claws was established on the basis of the statistical method stipulated by the EMA Guidelines (95% tolerance and 95% confidence).
DETERMINATION OF WDTS
• The moment (day) at which concentrations are equal to or lower than the LoD (20 µg kg-1) was determined.
• Analytes concentrations were lower the LoD at 39 (38.6) days for OTC and 54 (53.5) days for 4-epi-OTC
DISCUSSION AND CONCLUSIONS
• Chicken claws are a matrix in which the antimicrobial presence has not been studied until now.
• Thus, it was necessary to implement, optimize and validate an analytical method for OTC and its metabolite appropriate for its purpose.
• Main challenges found during the development of the method were the great amount of fat, cartilage and bone difficult extraction and sample cleaning.
DISCUSSION AND CONCLUSIONS
• Depletion study in chicken claws evidence that this matrix can be a source of antimicrobial residues entry into food chain.
• In broiler chickens treated with a commercial formulation OTC 10%, residues can be found in claws for long periods of time, which can even surpass the average life of a broiler chicken (42 days approximately).
• In order to observe the behavior in the matrix for the first time, sampling started at day 3 post-treatment, plus 3 more sampling points after de drug WDT.
• OTC is capable to accumulate and remain in bones, since it binds to the matrix directly through a complex between the calcium ions in the bone and the four rings of the basic tetracicline structure.
DISCUSSION AND CONCLUSIONS
• The presence of residues from these antimicrobials may become a risk for public health due to their direct effects and through the development of antimicrobial resistance
• Research in the antimicrobial re-entrance paths into the food chain by this or other alternative matrices is needed.
• The present study provides scientific foundations for establishing future regulations and monitoring residues in this matrix.
• Edible tissues??
• Project research team
• FARMAVET Laboratory
• Ekaterina Pokrant
• Aldo Maddaleno
ACKNOWLEDGEMENTS